Foster Dykema Cabot & Partners’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$599K Sell
5,831
-388
-6% -$43.8K 0.04% 65
2025
Q4
$779K Sell
6,219
-1,889
-23% -$241K 0.05% 59
2025
Q3
$1.09M Buy
8,108
+1,153
+17% +$151K 0.07% 50
2025
Q2
$946K Buy
6,955
+906
+15% +$119K 0.07% 50
2025
Q1
$802K Hold
6,049
0.06% 54
2024
Q4
$684K Sell
6,049
-1,445
-19% -$167K 0.05% 68
2024
Q3
$854K Buy
7,494
+1,343
+22% +$147K 0.07% 55
2024
Q2
$639K Sell
6,151
-115
-2% -$12.2K 0.06% 56
2024
Q1
$712K Buy
6,266
+1,001
+19% +$115K 0.07% 50
2023
Q4
$580K Buy
+5,265
New +$526K 0.06% 54

Other funds holding ABT

Foster Dykema Cabot & Partners's ABT Position: Q1 2026 in Review

Foster Dykema Cabot & Partners reduced its Abbott (ABT) stake by 6.2% in Q1 2026, selling an estimated $43.8K and leaving 5,831 shares worth $599K. The position accounts for 0.04% of the portfolio, ranked #65.

Foster Dykema Cabot & Partners first reported a position in ABT in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.09M in Q3 2025. 3,086 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Foster Dykema Cabot & Partners held 5,831 shares of Abbott worth $599K as of Q1 2026.
  • Foster Dykema Cabot & Partners sold 388 Abbott shares in Q1 2026, an estimated $43.8K.
  • Abbott made up 0.04% of Foster Dykema Cabot & Partners's portfolio in Q1 2026, its #65 holding.
  • Foster Dykema Cabot & Partners first reported a position in Abbott in Q4 2023 and has held it in 10 quarters since.
  • Foster Dykema Cabot & Partners's Abbott position peaked at $1.09M in Q3 2025.
  • 3,086 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q1 2026, filed 14 May 2026.